Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lukacs

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
European Urology|January 1, 1997
Using a large clinical database to assess the effectiveness of alfuzosinB Lukacs
Presse Medicale (Paris, France : 1983)|October 28, 1995
[Why and how to measure the quality of life? Questions to be asked by the urologist]B Lukacs
Prostate Cancer and Prostatic Diseases|December 24, 2002
Assessment of male sexual functionB Lukacs
European Urology|November 24, 1999
Management of symptomatic BPH in France: who is treated and how?B Lukacs
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1994
[The Medical Information System Program in urology: what should be considered?]B Lukacs, M Naidicht
Urology|March 29, 2000
One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General PracticeB Lukacs, J C Grange, D Comet
European Urology|January 1, 1993
Long-term quality of life in patients with benign prostatic hypertrophy: preliminary results of a cohort survey of 7,093 patients treated with an alpha-1-adrenergic blocker, alfuzosin. QOL BPH Study Group in General PracticeB Lukacs, C McCarthy, J C Grange
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 10, 2019
Voiding urethrocystoscopy: A new concept for benign prostatic obstruction characterizationB Lukacs, S Doizi, J-N Cornu
Urology|November 1, 1996
Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year resultsB Lukacs, A Leplège, P Thibault, et al.
Clinical Nephrology|June 1, 1986
Urokinase in patients dialyzed with HemasiteB Viron, B Lukacs, C Michel, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
European Urology|January 1, 1997
Using a large clinical database to assess the effectiveness of alfuzosinB Lukacs
Presse Medicale (Paris, France : 1983)|October 28, 1995
[Why and how to measure the quality of life? Questions to be asked by the urologist]B Lukacs
Prostate Cancer and Prostatic Diseases|December 24, 2002
Assessment of male sexual functionB Lukacs
European Urology|November 24, 1999
Management of symptomatic BPH in France: who is treated and how?B Lukacs
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1994
[The Medical Information System Program in urology: what should be considered?]B Lukacs, M Naidicht
Urology|March 29, 2000
One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General PracticeB Lukacs, J C Grange, D Comet
European Urology|January 1, 1993
Long-term quality of life in patients with benign prostatic hypertrophy: preliminary results of a cohort survey of 7,093 patients treated with an alpha-1-adrenergic blocker, alfuzosin. QOL BPH Study Group in General PracticeB Lukacs, C McCarthy, J C Grange
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 10, 2019
Voiding urethrocystoscopy: A new concept for benign prostatic obstruction characterizationB Lukacs, S Doizi, J-N Cornu
Urology|November 1, 1996
Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year resultsB Lukacs, A Leplège, P Thibault, et al.
Clinical Nephrology|June 1, 1986
Urokinase in patients dialyzed with HemasiteB Viron, B Lukacs, C Michel, et al.
Pageof 7